γ-谷氨酰转肽酶和血小板比值对肝癌介入术后急性肝功能恶化的预测作用

肝脏 ›› 2021, Vol. 26 ›› Issue (2): 175-178.

γ-谷氨酰转肽酶和血小板比值对肝癌介入术后急性肝功能恶化的预测作用

梅宝富, 邓志锋, 郑兰, 林堆贤

518000 广东深圳宝安区人民医院

收稿日期:2020-04-04 出版日期:2021-02-28 发布日期:2021-03-28
通讯作者: 林堆贤,Email:547056173@qq.com
基金资助:
深圳宝安区科技计划社会公益项目(2015006)

The value of gamma-glutamyl transpeptidase to platelet ratio index in predicting acute liver function deterioration after transarterial chemoembolization

MEI Bao-fu, DENG Zhi-feng, ZHENG Lan, LIN Dui-xian

The Bao'an District People's Hospital, Shenzhen, Guangdong, China

Received:2020-04-04 Online:2021-02-28 Published:2021-03-28
Contact: LIN Dui-xian,Email:547056173@qq.com

摘要/Abstract

摘要： 目的探讨γ-谷氨酰转肽酶和血小板比值指数(γ-glutamyl transpeptidase to platelet ratio index, GPRI)对原发性肝癌经导管动脉化疗栓塞(transcatheter arterial chemoembolization, TACE)术后发生急性肝功能恶化(acute liver function deterioration, ALFD)的预测作用。方法回顾性分析2015年6月至2019年12月接受TACE碘油栓塞治疗的141例肝癌临床资料,按文中标准分为ALFD组与对照组,对比两组患者的肝生化指标和GPRI,用ROC曲线和分层卡方检验分析GPRI指数对TACE术后ALFD的预测能力。结果 ALFD组Child评分、GPRI指数明显高于对照组,差异有统计学意义。Child-Pugh评分、GPRI AUC分别为0.774、0.784,差异无统计学意义,最佳截点值分别为2.02、6。预测TACE术后ALFD的敏感度、特异度、阳性预测值(PPV)、阴性预测值(NPV)和正确率分别为0.735、0.785、0.521、0.903、0.779和0.588、0.888、0.606、0.870、0.808。分层分析显示,GPRI＞2.02是ALFD的危险因素。结论 GPRI对肝癌TACE术后ALFD风险具有一定预测价值,GPRI≤2.02可以安全接受TACE治疗,有助于筛选术后ALFD风险难以确定的Child-Pugh B级肝癌患者。

关键词: γ-谷氨酰转肽酶和血小板比值指数, 肝癌, 经导管动脉化疗栓塞术, 急性肝功能恶化

Abstract: Objective To investigate the value of gamma-glutamyl transpeptidase to platelet ratio index (GPRI) in predicting acute liver function deterioration (ALFD) in patients with primary liver cancer after transarterial chemoembolization (TACE).Methods The clinical data of 141 primary liver cancer patients treated with TACE in our hospital from June 2015 to December 2019 were retrospectively analyzed. The patients were divided into ALFD group and control group. The t test and χ² test were used to compare the clinical data between 2 groups. The predictive value of Child-Pugh score and GPRI was assessed by receiver operating characteristic (ROC) curve. Results The Child-Pugh score and GPRI of ALFD group were significantly higher than those of control group. The area under the ROC curve (AUC) and cut-off value of Child-Pugh score were 0.774 and 6. The AUC of GPRI were 0.784 and 2.02. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of Child-Pugh score were 58.8%, 88.8%, 60.6%, 87.0% and 80.8%, respectively. The sensitivity, specificity, PPV, NPV and accuracy of GPRI were 73.5%, 78.5%, 52.1%, 90.3% and 77.9%, respectively. GPRI > 2.02 was risk factor for ALFD.Conclusion GPRI is valuable in predicting ALFD after TACE. It is safe to receive TACE when pre-operation GPRI ≤ 2.02, which is helpful for evaluating the risk of ALFD in Child-Pugh B patients.

Key words: Gamma-glutamyl transpeptidase to platelet ratio index, Hepatocellular carcinoma, Transarterial chemoembolization, Acute liver function deterioration

梅宝富, 邓志锋, 郑兰, 林堆贤. γ-谷氨酰转肽酶和血小板比值对肝癌介入术后急性肝功能恶化的预测作用[J]. 肝脏, 2021, 26(2): 175-178.

MEI Bao-fu, DENG Zhi-feng, ZHENG Lan, LIN Dui-xian. The value of gamma-glutamyl transpeptidase to platelet ratio index in predicting acute liver function deterioration after transarterial chemoembolization[J]. Chinese Hepatolgy, 2021, 26(2): 175-178.

参考文献

[1] Chen WQ, Zheng RS, Baade PD, et al. Cancer statistics in China, 2015.CA Cancer J Clin, 2016, 66:115-132.
[2] 中华人民共和国卫生和计划生育委员会医政医管局. 原发性肝癌诊疗规范(2017年版).中华消化外科杂志, 2017, 16:635-647.
[3] Wang Z, Ren ZG Chen YI, et al. Adjuvant Transarterial hemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study. Clin Cancer Res, 2018, 24:2074-2079.
[4] Park JW, Chen MS, Colombo M, et al. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study. Liver Int, 2015, 35: 2155-2166.
[5] 宋裕萍, 赵擎宇, 李松, 等. 非侵人性肝纤维化诊断模型对肝癌介入治疗后急性肝功能恶化的预测作用. 中华医学杂志, 2016, 96:716-719.
[6] Wang RQ, Zhang QS, Zhao SX, et al. Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients. J Int Med Res, 2016, 44:1302-1313.
[7] Lemoine M, Shimakawa Y, Nayagam S, et al. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa. Gut, 2016, 65:1369-1376.
[8] 杨银山, 黄明, 宋飞, 等. 肝癌介入治疗后急性肝功能恶化风险的无创检查研究. 肝脏, 2019, 24:1282-1284.
[9] 王梅, 尉从新, 杨贵华, 等.肝硬化CT分级评估肝癌介入治疗肝储备功能及预后的临床价值. 中国老年学杂志, 2017, 37:2197-2198.
[10] Wu X, Cai B, Su Z, et al. Aspartate transaminase to platelet ratio index and gamma-glutamyl transpeptidase-to-platelet ratio outweigh fibrosis index based on four factors and red cell distribution width-platelet ratio in diagnosing liver fibrosis and inflammation in chronic hepatitis B. J Clin Lab Anal, 2018, 32:e22341.
[11] Hu YC, Liu H, Liu XY, et al. Value of gamma-glutamyl transpeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B. World J Gastroenterol, 2017, 23:7425-7432.
[12] Park YE, Kim BK, Park JY, et al. Gamma-glutamyl transpeptidase to platelet ratio is an independent predictor of hepatitis B virus-related liver cancer. J Gastroenterol Hepatol, 2017, 32:1221-1229.
[13] Zhu YF, Tan YF, Xu X, et al. Gamma-glutamyl transpeptidase-to-platelet ratio and the fibrosis-4 index in predicting hepatitis B virus-related hepatocellular carcinoma development in elderly chronic hepatitis B patients in China: A single-center retrospective study. Medicine (Baltimore), 2019, 98:e18319.
[14] Huang L, Mo Z, Hu Z, et al. Diagnostic value of fibrinogen to prealbumin ratio and gamma-glutamyl transpeptidase to platelet ratio in the progression of AFP-negative hepatocellular carcinoma. Cancer Cell Int, 2020, 20:77.
[15] 董菁菁, 王允野, 刘昆, 等. γ-谷氨酰转肽酶和血小板比值指数对慢性乙型肝炎肝纤维化的诊断价值. 中华传染病杂志, 2017, 35:670-674.